Global Hematopoietic Stem Cells Transplantation Market Growth (Status and Outlook) 2023-2029

Global Hematopoietic Stem Cells Transplantation Market Growth (Status and Outlook) 2023-2029

Over 50 years of studies in the field of blood-forming stem cells i.e. hematopoietic stem cells (HSC), researchers have developed significant understanding to use HSCs as a therapy. At present, no type of stem cell, adult, embryonic or fetal has attained such sufficient status. Hematopoietic stem cell transplantation (HSCT) is now routinely used for treating patients with malignant and non-malignant disorders of blood and the immune system. Currently, researchers have observed that through animal studies HSCs have the ability to form other cells such as blood vessels, muscles, and bone.
LPI (LP Information)' newest research report, the “Hematopoietic Stem Cells Transplantation Industry Forecast” looks at past sales and reviews total world Hematopoietic Stem Cells Transplantation sales in 2022, providing a comprehensive analysis by region and market sector of projected Hematopoietic Stem Cells Transplantation sales for 2023 through 2029. With Hematopoietic Stem Cells Transplantation sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Hematopoietic Stem Cells Transplantation industry.
This Insight Report provides a comprehensive analysis of the global Hematopoietic Stem Cells Transplantation landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Hematopoietic Stem Cells Transplantation portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Hematopoietic Stem Cells Transplantation market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Hematopoietic Stem Cells Transplantation and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Hematopoietic Stem Cells Transplantation.
The global Hematopoietic Stem Cells Transplantation market size is projected to grow from US$ 2364.6 million in 2022 to US$ 3535.1 million in 2029; it is expected to grow at a CAGR of 5.9% from 2023 to 2029.
Market competition is intense. CBR Systems, China Cord Blood Corporation, ViaCord, Thermo Fisher Scientific, STEMCELL Technologies etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; with the development of society and the changing of consumer demand, there will be more companies enter this industry. Top 5 players accounted for about 32.09% market share.
This report presents a comprehensive overview, market shares, and growth opportunities of Hematopoietic Stem Cells Transplantation market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Stem Cells Storage
Stem Cells Consumables
Segmentation by application
Leukemia
Lymphoproliferative Disorders
Solid Tumors
Non-Malignant Disorders
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
CBR Systems
China Cord Blood Corporation
ViaCord
Thermo Fisher Scientific
STEMCELL Technologies
Vcanbio
Merck Millipore
Lonza Group
CellGenix Technologie Transfer
ThermoGenesis

Please note: The report will take approximately 2 business days to prepare and deliver.